Adelene Perkins Latest Insider Activity
Management EfficiencyThe company has return on total asset (ROA) of (28.6) % which means that it has lost $28.6 on every $100 spent on asset. This is way below average. Similarly, it shows return on stockholders equity (ROE) of (59.0) % meaning that it created substantial loss on money invested by shareholders.
Entity SummaryInfinity Pharmaceuticals, Inc., a biopharmaceutical company, develops medicines for people with cancer in the United States. Infinity Pharmaceuticals, Inc. is headquartered in Cambridge, Massachusetts. Infinity Pharmaceuticals operates under Biotechnology classification in USA and traded on BATS Exchange. It employs 22 people.Infinity Pharmaceuticals (INFI) is traded on BATS Exchange in USA. It is located in MASSACHUSETTS U.S.A and employs 22 people. Infinity Pharmaceuticals is listed under Pharmaceutical Products category by Fama And French industry classification.
Infinity Pharmaceuticals Leadership Team
Stock Performance Indicators